Quantity :1
Title: Investing in the human genome.
Author : Fisher, Lawrence M.
The major drug companies have already paid hundreds of millions of dollars to the genomics companies to gain access to their data, and the betting is that the health care system will one day pay billions for genomics-based drugs. the shares may be volatile, and investors may want to use big movements as trading opportunities, but, basically, those who believe the thesis may want to own these stocks almost regardless of how expensive they become. And those who do not believe it, of course, may want to stay away.
Subject:
biotechnology biosafety genetically modified organisms : GMOs genetics human genome DNA
Material : biotech
Publication Date : November 1999
PR-AM
1999
BIC517
SEARCA Library
Printed